We propose to pool data from five HIV cohort studies to answer pivotal questions in the management of patients with HIV infection: when to initiate Highly Active Antiretroviral Therapy (HAART)?, which HAART regimes work better as initial treatment?, and when to switch to another HAART regime? Observational cohort studies are appropriate for this analyses as they are more cost-efficient than randomized trials, use less restrictive eligibility criteria than randomized trials, and, when analyzed appropriately analyzed have provided estimates of the efficacy of HAART close to those obtained from the randomized trials. Nevertheless, because of sample size considerations, it is unlikely that any single cohort will be sufficient to obtain stable estimates. We therefore pool data from five ongoing prospective cohort studies in Western Europe and North America: the Veterans Aging Cohort Study (USA), the Swiss HIV Cohort Study (Switzerland), the French Hospital Database HIV Study (France), GEMES (Spain), and PISCIS (Catalonia and Balearic Islands, Spain). Together, these studies have recruited more than 140,000 HIV infected patients. We will use the data from several observational cohorts in a way that mimics the design of randomized trials as closely as possible. We will then apply inverse probability weighting, g-estimation, and the parametric g- formula (methods developed by Robins and collaborators over the last two decades). These methods are not only theoretically valid to address these questions but have also successfully reproduced results from previous randomized trials when applied to observational data. Our study will inform evidence-based guidelines, and the planning of clinical trials. In addition, the successful application of this advanced methodology as proposed will facilitate understanding and training in causal modeling across leading HIV observational research groups in the United States and Europe. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI073127-01A2
Application #
7336956
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Mckaig, Rosemary G
Project Start
2007-08-15
Project End
2011-07-31
Budget Start
2007-08-15
Budget End
2008-07-31
Support Year
1
Fiscal Year
2007
Total Cost
$366,750
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Murray, Eleanor J; Robins, James M; Seage 3rd, George R et al. (2018) Using Observational Data to Calibrate Simulation Models. Med Decis Making 38:212-224
Murray, Eleanor J; Robins, James M; Seage, George R et al. (2017) A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference. Am J Epidemiol 186:131-142
Caniglia, Ellen C; Cain, Lauren E; Sabin, Caroline A et al. (2017) Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. Lancet HIV 4:e251-e259
Caniglia, Ellen C; Sabin, Caroline; Robins, James M et al. (2016) When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study. J Acquir Immune Defic Syndr 72:214-21
Cain, Lauren E; Saag, Michael S; Petersen, Maya et al. (2016) Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. Int J Epidemiol 45:2038-2049
Cain, Lauren E; Caniglia, Ellen C; Phillips, Andrew et al. (2016) Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals. Medicine (Baltimore) 95:e5133
HIV-CAUSAL Collaboration; Cain, Lauren E; Phillips, Andrew et al. (2015) Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. Clin Infect Dis 60:1262-8
Gruber, Susan; Logan, Roger W; Jarrín, Inmaculada et al. (2015) Ensemble learning of inverse probability weights for marginal structural modeling in large observational datasets. Stat Med 34:106-17
Swanson, Sonja A; Hernán, Miguel A (2014) Think globally, act globally: An epidemiologist's perspective on instrumental variable estimation. Stat Sci 29:371-374
Westreich, Daniel; Cole, Stephen R; Young, Jessica G et al. (2012) The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med 31:2000-9

Showing the most recent 10 out of 23 publications